These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31931917)

  • 21. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpretation of repeat tuberculin skin testing in international adoptees: conversions or boosting.
    Mandalakas AM; Kirchner HL; Zhu X; Yeo KT; Starke JR
    Pediatr Infect Dis J; 2008 Oct; 27(10):913-9. PubMed ID: 18776820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial.
    Ruhwald M; Aggerbeck H; Gallardo RV; Hoff ST; Villate JI; Borregaard B; Martinez JA; Kromann I; Penas A; Anibarro LL; de Souza-Galvão ML; Sánchez F; Rodrigo-Pendás JÁ; Noguera-Julian A; Martínez-Lacasa X; Tuñez MV; Fernández VL; Millet JP; Moreno A; Cobos N; Miró JM; Roldan L; Orcau A; Andersen P; Caylá JA;
    Lancet Respir Med; 2017 Apr; 5(4):259-268. PubMed ID: 28159608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
    Wilson FA; Miller TL; Stimpson JP
    Public Health Rep; 2016; 131(2):303-10. PubMed ID: 26957665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern recognition technique in immunological antigenic tests to identify Mycobacterium tuberculosis infection.
    Selvaraj R; Gopal G; Raja A; Kumaraswami V
    Tuberculosis (Edinb); 2002; 82(6):261-6. PubMed ID: 12623268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous comparison of reactivity to purified protein derivative RT-23 and Tubersol in health care workers in Vitória, Brazil.
    Teixeira L; Maciel E; Dutra ME; Perkins MD; Johnson JL; do Valle Dettoni V
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1074-7. PubMed ID: 11092721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.
    Kurti Z; Lovasz BD; Gecse KB; Balint A; Farkas K; Morocza-Szabo A; Gyurcsanyi A; Kristof K; Vegh Z; Gonczi L; Kiss LS; Golovics PA; Lakatos L; Molnar T; Lakatos PL
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):467-72. PubMed ID: 26697573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012.
    Miramontes R; Hill AN; Yelk Woodruff RS; Lambert LA; Navin TR; Castro KG; LoBue PA
    PLoS One; 2015; 10(11):e0140881. PubMed ID: 26536035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.
    Machingaidze S; Wiysonge CS; Gonzalez-Angulo Y; Hatherill M; Moyo S; Hanekom W; Mahomed H
    Pediatr Infect Dis J; 2011 Aug; 30(8):694-700. PubMed ID: 21427627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the level of IFN-γ produced by T cells in response to Mycobacterium tuberculosis-specific antigens with the size of skin test indurations among individuals with latent tuberculosis in a highly tuberculosis-endemic setting.
    Legesse M; Ameni G; Mamo G; Medhin G; Bjune G; Abebe F
    Int Immunol; 2012 Feb; 24(2):71-8. PubMed ID: 22298884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yield of tuberculosis contact investigations in Amsterdam: opportunities for improvement.
    Sloot R; Schim van der Loeff MF; Kouw PM; Borgdorff MW
    Eur Respir J; 2014 Sep; 44(3):714-24. PubMed ID: 25063246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
    Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
    PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concordance of a positive tuberculin skin test and an interferon gamma release assay in bacille Calmette-Guérin vaccinated persons.
    Mahan CS; Johnson DF; Curley C; van der Kuyp F
    Int J Tuberc Lung Dis; 2011 Feb; 15(2):174-8, i. PubMed ID: 21219677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-gamma release assays piloted as a latent tuberculous infection screening tool in Canadian federal inmates.
    Schwartz IS; Bach PJ; Roscoe B; Majury A; Hopman WM; Ellis E; Garrahan T; Smith J; Barkley R; Panaro L; Jamieson F; Froats C; Gemmill I; Wobeser WL
    Int J Tuberc Lung Dis; 2014 Jul; 18(7):787-92. PubMed ID: 24902553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis skin test, but not interferon-γ-releasing assays is affected by BCG vaccination in HIV patients.
    Wolf T; Goetsch U; Oremek G; Bickel M; Khaykin P; Haberl A; Bellinger O; Gottschalk R; Brodt HR; Stephan C
    J Infect; 2013 Apr; 66(4):376-80. PubMed ID: 23159357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.
    Blount RJ; Tran MC; Everett CK; Cattamanchi A; Metcalfe JZ; Connor D; Miller CR; Grinsdale J; Higashi J; Nahid P
    BMC Public Health; 2016 Aug; 16(1):875. PubMed ID: 27558397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current tuberculin reactivity of schoolchildren in the Central African Republic.
    Minime-Lingoupou F; Ouambita-Mabo R; Komangoya-Nzozo AD; Senekian D; Bate L; Yango F; Nambea B; Manirakiza A
    BMC Public Health; 2015 May; 15():496. PubMed ID: 25981707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm).
    Gudjónsdóttir MJ; Kötz K; Nielsen RS; Wilmar P; Olausson S; Wallmyr D; Trollfors B
    BMC Infect Dis; 2016 Oct; 16(1):540. PubMed ID: 27716176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.